Evaluation of preference for a buprenorphine-based maintenance therapy, after a switch from buprenorphine alone (Subutex) to the buprenorphine/naloxone combination (Suboxone), in opioid-dependent patients with buprenorphine maintenance therapy.

Trial Profile

Evaluation of preference for a buprenorphine-based maintenance therapy, after a switch from buprenorphine alone (Subutex) to the buprenorphine/naloxone combination (Suboxone), in opioid-dependent patients with buprenorphine maintenance therapy.

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Jan 2016

At a glance

  • Drugs Buprenorphine/naloxone (Primary) ; Buprenorphine
  • Indications Pain
  • Focus Therapeutic Use
  • Acronyms COMPLETED
  • Sponsors Reckitt Benckiser; Schering-Plough
  • Most Recent Events

    • 22 Jul 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top